Sponsored by

Chimerix

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 26 to 50 of about 5822

Previous 25

Website Changes

07/01/2024

Exhaustive in vitro evaluation of the 9-drug cocktail CUSP9 for treatment of glioblastoma

07/01/2024

Musella Foundation Awards Research Grant

06/23/2024

FDA Expands Orphan Drug Designation for SurVaxM, Immunotherapy Developed at Roswell Park

06/13/2024

Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following Treatment with Bizaxofusp When Compared to a Matched External Control Arm at the 2024 ASCO Annual Meeting

06/12/2024

Musella Foundation Earns a Four-Star Rating From Charity Navigator

06/03/2024

VBI Vaccines Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients

06/03/2024

METIS Phase 3 Clinical Trial Met Primary Endpoint Significantly Delaying Time to Intracranial Progression with Improved Quality of Life Deterioration-Free Survival

06/03/2024

Brain Cancer Support and Solutions Alliance Launched to Improve Care and Outcomes for Brain Tumor Patients

06/03/2024

For Love & Life: No Ordinary Campaign

05/28/2024

Introducing Promising Pathway 2.0

05/28/2024

Musella Foundation Awards 3 Research Grants!

05/28/2024

Brain Tumor Awareness Month Webinar Series

05/27/2024

Can Boosting Hydrogen Sulfide Bolster Standard-of-Care Glioblastoma Therapy to Extend Survival?

05/27/2024

Ivy Brain Tumor Center announces Phase 0/2 clinical readout of niraparib indicating significant improvement in overall survival of newly diagnosed glioblastoma patients

05/23/2024

IMVAX Announces Completion of Enrollment in Phase 2b Clinical Trial of IGV-001 and Successful Financing

05/23/2024

President Lech Walesa of Poland Announces Plan to Harness Wind and Solar Energy to Discover Cancer Treatments and Cures

05/21/2024

URGENT - Promising Pathway 2.0!

05/21/2024

Brain Tumor Awareness Month Webinar Series

05/20/2024

Brain Tumor Awareness Month Webinar Today

05/16/2024

Brain Tumor Awareness Month Webinar Tonight

05/13/2024

Musella Foundation Celebrates 26th Anniversary!

05/12/2024

TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II trial

05/12/2024

Brain Tumor Awareness Month Webinar Series

05/06/2024

CIRM Awards $11.8 Million Grant for Clinical Trial in High-Grade Glioma Including Glioblastoma Using DB107, a Novel DGM7 Genetic Biomarker-Guided Gene Therapy

05/06/2024

Minnesota Brain Tumor 5k Announces 15th Annul Fun Walk/Run

Our privacy / cookie policy has changed.
Click HERE to read it!